The recent acquisition of Gigamoto Technology Partners (W. Conshohocken, PA) expands United BioSource Corporation's (Bethesda, MD) leadership in drug safety, the company says. The purchase is UBC's second of the year and provides the company with several risk management programs, including the largest and longest running FDA-mandated program: iPLEDGE, an interactive computer-based distribution center that monitors pregnancy in women on Accutane.
“Managing drug safety for increasingly complex drugs and biologicals requires world class scientific expertise, strong operations, and demands state of the art technology,” said Ethan Leder, Chief Executive Officer of United Biosource. “The acquisition of Gigamoto enhances and accelerates our technology platform to include more top-notch FDA approved technology solutions for complex post-approval programs."
The full press release is available here.